Jan 30, 2026 04:15PM
Nov 17, 2025 08:30AM
Aug 28, 2025 08:00AM
May 13, 2025 08:00AM
May 6, 2025 07:30AM
Apr 28, 2025 08:00AM
Apr 2, 2025 04:10PM Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
Apr 4, 2024 05:06PM
Sep 26, 2023 08:30AM
Jul 10, 2023 08:00AM
Jun 1, 2023 08:00AM
May 9, 2023 07:00AM
Mar 29, 2023 05:00PM
Dec 14, 2022 05:03PM Galmed Pharma (GLMD) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement
Dec 14, 2022 05:00PM
Aug 4, 2022 08:00AM
Jul 7, 2022 08:28AM
Jul 7, 2022 08:27AM
May 17, 2022 08:00AM
May 17, 2022 07:33AM
May 17, 2022 07:30AM Galmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effects
May 2, 2022 07:00AM
Apr 26, 2022 08:30AM
Jan 10, 2022 07:30AM
Nov 8, 2021 07:31AM
Nov 8, 2021 07:30AM
Nov 8, 2021 07:00AM
Nov 1, 2021 10:10AM Galmed Announces Positive Results from First 16 Patients in Open-Label Part of ARMOR Study
Aug 19, 2021 08:00AM
Aug 16, 2021 08:00AM
Aug 5, 2021 07:00AM
Jul 29, 2021 08:30AM
May 6, 2021 08:30AM
May 3, 2021 08:32AM
May 3, 2021 08:30AM Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational Study
Mar 18, 2021 07:00AM
Mar 16, 2021 08:00AM
Mar 11, 2021 08:30AM
Feb 16, 2021 09:30AM
Feb 16, 2021 09:29AM
Feb 16, 2021 06:49AM
Feb 16, 2021 06:48AM Galmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares
Jan 19, 2021 08:00AM
Nov 12, 2020 07:00AM
Nov 9, 2020 08:00AM
Nov 5, 2020 08:30AM
Sep 10, 2020 08:49AM
Aug 6, 2020 07:00AM
Aug 6, 2020 06:50AM Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER program
Jul 30, 2020 08:30AM

322,209 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All